Related Experiment Video

Updated: May 27, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Role of JNK in mammary gland development and breast cancer

Cristina Cellurale1, Nomeda Girnius, Feng Jiang

  • 1Howard Hughes Medical Institute and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

Cancer Research
|December 1, 2011
PubMed

Insights

cJun NH(2)-terminal kinase (JNK) signaling is crucial for normal mammary gland development. Loss of JNK1/2 in mice increased breast tumor formation, indicating JNK signaling suppresses breast cancer development.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Cancer Research

Background:

  • cJun NH(2)-terminal kinase (JNK) signaling pathways are involved in epithelial organ development.
  • The specific role of JNK1 and JNK2 in mammary gland development and tumorigenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of JNK1 and JNK2 in mouse mammary gland development.
  • To determine the impact of JNK1/2 deficiency on mammary gland morphogenesis and epithelial cell dynamics.
  • To evaluate the effect of JNK1/2 loss on breast cancer development and progression.

Main Methods:

  • Compound deletion of Jnk1 and Jnk2 genes in the murine mammary gland.
  • Assessment of breast epithelial cell proliferation and motility.
  • Analysis of branching morphogenesis and lumenal epithelial cell clearance.
  • Evaluation of mammary tumor formation in JNK1/2 deficient mice.

Main Results:

  • JNK1/2 was not essential for breast epithelial cell proliferation or motility.
  • JNK1/2 deficiency led to enhanced branching morphogenesis.
  • Defects in lumenal epithelial cell clearance were observed in JNK1/2 deficient mammary glands.
  • Loss of JNK1/2 significantly increased mammary tumor incidence.

Conclusions:

  • JNK signaling is required for proper mammary gland development.
  • JNK1/2 plays a suppressive role in mammary tumorigenesis.
  • Targeting JNK pathways may offer therapeutic strategies for breast cancer.

More Related Videos

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland11:13

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland

Published on: December 1, 2015

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...